
Singapore · Research startup
Novotech is a full-service clinical research organization (CRO) and scientific advisory partner, founded in 1997.
Follow Novotech and see its new rounds in your feed.Sign up free
Funding reportedLast round: Venture (Round not Specified)
Novotech is a full-service clinical research organization (CRO) and scientific advisory partner, founded in 1997.
Headquartered in Singapore, with a significant presence in Sydney, Australia, the company specializes in accelerating drug development for biotech and small- to mid-sized pharmaceutical companies. Novotech operates over 30 offices across Asia-Pacific, North America, and Europe, employing around 2,800 to 3,000 professionals globally. The company offers comprehensive clinical development services that cover the entire trial lifecycle, from Phase I to Phase IV. Its services include clinical trials, bioequivalence studies, patient recruitment, drug development consulting, and regulatory expertise. Novotech has successfully conducted more than 5,000 clinical projects and has played a role in bringing over 60 drugs to market. It is recognized as Australia’s largest independent CRO and has received multiple awards for its contributions to the industry.
Funding, as reported
From Novotech's own website: 26 on the team.
And 8 more on the team.
What they build
Known for
health careus crolab servicesbiotechnology researchdata managementregulatory affairshospital & health caresouth korea crohealthbiostatisticsleading asia pacific contract research organizationauditingclinical research organizationbest cro in australiaeurope croaudits
Built with from their website
CertiniaServiceNowAdobeSAS Analytics ProGoogle Tag ManagerExcel ImpactNAVERSTARLIMSMicrosoft Defender for EndpointACL
IroncladSalesforce CRM AnalyticsHREF LangAtlassianPWAPower QueryGoogle CloudMicrosoft PowerPoint
Add your raise, your deck and your story, and put Novotech in front of investors. Or tell us what we have wrong.